Prestige Consumer Healthcare Inc.
NYSE:PBH · New York Stock Exchange
+$0.23 today
Vol 1.27M · Avg 0.67M
Balance Sheet
Inspect the capital base behind the business
Review assets, liabilities, equity, cash, and debt to judge whether the company has the financial position to support future returns.
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $63.9M |
| Receivables | $191.9M |
| Inventory | $159.1M |
| Other Current | $16.6M |
| Total Current Assets | $431.5M |
| PP&E (Net) | $171.2M |
| Goodwill | $581.1M |
| Intangible Assets | $2.3B |
| Tax Assets | $62.0M |
| Other Non-current | $2.2M |
| Total Non-current Assets | $3.1B |
| Total Assets | $3.5B |
Analysis
Selected assets total $3.5B for Latest. The largest visible component is Intangible Assets at $2.3B, about 64.8% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Balance Sheet
Annual data · 5 periods
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $63.9M -34.8% | $97.9M +110.6% | $46.5M -20.6% | $58.5M +115.2% | $27.2M | $1.2B | $1.0B | $841.8M |
| Short-term Investments | $0 | $0 | $0 | $0 | $0 | -$1.7B | -$1.6B | $445.6M |
| Net Receivables | $191.9M -1.2% | $194.3M +9.9% | $176.8M +5.8% | $167.0M +19.9% | $139.3M | $668.2M | $533.8M | $399.4M |
| Inventory | $159.1M +7.7% | $147.7M +6.5% | $138.7M -14.4% | $162.1M +34.7% | $120.3M | $652.8M | $641.6M | $328.0M |
| Other Current Assets | $16.6M +96.2% | $8.4M -35.5% | $13.1M +217.8% | $4.1M | $0 | -$1.7B | $1.5B | $966.4M |
| Total Current Assets | $431.5M -3.8% | $448.3M +19.5% | $375.0M -4.3% | $391.7M +33.6% | $293.3M | $3.6B | $12.5B | $10.5B |
| Property, Plant & Equipment (Net) | $171.2M +34.0% | $127.8M +43.1% | $89.3M -0.2% | $89.5M -9.1% | $98.5M | $575.8M | $1.2B | $1.5B |
| Goodwill | $581.1M +10.2% | $527.4M -0.1% | $527.7M +0.0% | $527.6M -8.9% | $579.0M | $1.4B | $925.8M | $466.6M |
| Intangible Assets | $2.3B +0.2% | $2.3B -1.1% | $2.3B -0.9% | $2.3B -13.2% | $2.7B | $1.4B | $568.8M | $860.0M |
| Long-term Investments | $0 | $0 | $0 | $0 | $0 | $1.2B | $524.0M | -$1.5B |
| Tax Assets | $62.0M | $0 | $0 | $0 | $0 | $364.4M | $1.5B | $1.4B |
| Other Non-current Assets | $2.2M -33.7% | $3.3M -42.8% | $5.7M +90.5% | $3.0M -8.2% | $3.3M | $1.4B | $1.4B | $1.0B |
| Total Non-current Assets | $3.1B +5.5% | $3.0B +0.4% | $2.9B -0.6% | $3.0B -12.3% | $3.4B | $4.7B | -$15.3B | $14.8B |
| Total Assets | $3.5B +4.3% | $3.4B +2.5% | $3.3B -1.1% | $3.4B -8.6% | $3.7B | $14.6B | $13.3B | $11.9B |
| Account Payables | $22.8M +20.4% | $18.9M -51.4% | $39.0M -37.9% | $62.7M +12.5% | $55.8M | $1.2B | $1.3B | -$1.5B |
| Short-term Debt | $3.0M | $0 | $0 | $0 | $0 | $1.2B | -$1.6B | -$1.6B |
| Tax Payables | $0 -100.0% | $830.0K -67.7% | $2.6M -75.9% | $10.6M +299.6% | $2.7M | $708.8M | $574.4M | -$1.5B |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 | $340.6M | -$1.6B | $374.2M |
| Other Current Liabilities | $12.1M -14.6% | $14.2M -75.1% | $57.1M +299.7% | $14.3M -27.0% | $19.6M | $650.0M | $1.1B | $1.5B |
| Total Current Liabilities | $120.9M +13.4% | $106.6M -8.9% | $117.0M -27.2% | $160.7M +12.1% | $143.4M | $12.8B | $6.0B | $10.1B |
| Long-term Debt | $994.0M +0.2% | $992.4M -11.9% | $1.1B -16.3% | $1.3B -8.9% | $1.5B | $483.4M | $1.3B | $438.6M |
| Deferred Tax Liabilities | $500.7M +19.3% | $419.6M +4.0% | $403.6M +6.1% | $380.4M -14.5% | $444.9M | $1.2B | $746.6M | $612.2M |
| Deferred Revenue (Non-current) | $0 | $0 | $0 | $0 | $0 | $1.0B | -$1.6B | $715.8M |
| Other Non-current Liabilities | $5.6M +3.5% | $5.4M -41.3% | $9.2M +12.5% | $8.2M +9.1% | $7.5M | $1.2B | $489.0M | $1.1B |
| Total Non-current Liabilities | $1.5B +5.4% | $1.5B -5.5% | $1.5B -11.4% | $1.7B -10.4% | $1.9B | $11.3B | $3.9B | $7.5B |
| Total Liabilities | $1.7B +5.9% | $1.6B -5.8% | $1.7B -12.8% | $1.9B -8.9% | $2.1B | $8.8B | $14.7B | $3.7B |
| Common Stock | $562.0K +0.4% | $560.0K +0.9% | $555.0K +1.3% | $548.0K +0.7% | $544.0K | $785.8M | $651.4M | $517.0M |
| Retained Earnings | $1.7B +12.2% | $1.6B +16.0% | $1.3B +18.5% | $1.1B -6.8% | $1.2B | $1.0B | -$1.6B | $519.8M |
| Accumulated OCI | -$28.4M +24.7% | -$37.7M -9.2% | -$34.5M -9.3% | -$31.6M -65.8% | -$19.0M | -$1.6B | $393.8M | $550.6M |
| Other Stockholders Equity | $0 | $0 | $0 | $0 | $0 | $486.2M | $351.8M | -$1.6B |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $853.0M | $1.4B | $337.8M |
| Total Equity | $1.9B +2.9% | $1.8B +10.9% | $1.7B +14.4% | $1.4B -8.3% | $1.6B | $10.4B | $9.1B | $7.7B |
| Total Debt | $1.0B +0.1% | $1.0B -8.4% | $1.1B -16.6% | $1.4B -9.2% | $1.5B | $735.4M | $724.2M | $410.6M |
| Net Debt | $981.6M +3.7% | $946.4M -13.4% | $1.1B -16.5% | $1.3B -11.5% | $1.5B | -$1.7B | $389.6M | $501.6M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Legend Biotech Corporation
NASDAQ:LEGN
$5.33B
LivaNova PLC
NASDAQ:LIVN
$4.34B
Catalyst Pharmaceuticals, Inc.
NASDAQ:CPRX
$3.84B
Concentra Group Holdings Parent, Inc.
NYSE:CON
$3.65B
ICU Medical, Inc.
NASDAQ:ICUI
$3.49B
Privia Health Group, Inc.
NASDAQ:PRVA
$2.97B
Heartflow, Inc. Common Stock
NASDAQ:HTFL
$2.88B
Disc Medicine, Inc.
NASDAQ:IRON
$2.68B
Zai Lab Limited
NASDAQ:ZLAB
$2.08B
Alphatec Holdings, Inc.
NASDAQ:ATEC
$1.33B
SEC Filings
Recent regulatory filings
No filings found.
How much cash does PBH have?
Prestige Consumer Healthcare Inc. (PBH) reported $63.87M in cash and equivalents in fiscal 2026.
How much debt does PBH carry?
Prestige Consumer Healthcare Inc. (PBH) reported $1.05B of total debt, with net debt of $981.56M.
Explore More
Continue the stock analysis
Jump to another research area for this company.